AbbVie
ABBV
#30
Rank
A$481.13 B
Marketcap
$272.27
Share price
0.10%
Change (1 day)
18.39%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of December 2024 (TTM): 5.52

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 50.5. At the end of 2024 the company had a P/S ratio of 6.20.

P/S ratio history for AbbVie from 2012 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20246.2023%
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.41-56.29%๐Ÿ‡บ๐Ÿ‡ธ USA
2.38-56.77%๐Ÿ‡บ๐Ÿ‡ธ USA
17.4 214.80%๐Ÿ‡บ๐Ÿ‡ธ USA
4.47-18.95%๐Ÿ‡บ๐Ÿ‡ธ USA
4.05-26.67%๐Ÿ‡บ๐Ÿ‡ธ USA
2.28-58.75%๐Ÿ‡บ๐Ÿ‡ธ USA
1.73-68.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
4.08-25.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
5.72 3.68%๐Ÿ‡บ๐Ÿ‡ธ USA